Brief

Weight-Loss Drug MDL In Pa. Grows With 3 New Jersey Cases

By P.J. D'Annunzio · November 13, 2025, 7:04 PM EST

Three New Jersey cases were grouped into multidistrict litigation accusing Eli Lilly & Co. and Novo Nordisk of downplaying alleged side effects of weight loss drugs like Ozempic and Trulicity, according...

To view the full article, register now.

Documents

Case Information

Case Title

GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION

Case Number

2:24-md-03094

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 05, 2024